Drug manufacturers must advise health care providers about risks a drug may present to a patient's close contacts, a New York judge has ruled. The ruling came in a case where the father of a child being vaccinated against polio contracted paralytic poliomyelitis. The father alleged that his polio came as a result of contact with his daughter, who in 1979 had received an oral polio vaccine made by Lederle Laboratories.
July 14, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drug manufacturers must advise health care providers about risks a drug may present to a patient’s close contacts, a Staten Island Supreme Court justice has ruled in a case of first impression for New York state courts.
Justice William F. Mastro adopted a recent recommendation contained in the Restatement (Third) of Torts in a case where the father of a child being vaccinated against polio contracted paralytic poliomyelitis.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
